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Abstract 
 
In vitro fish based models have been extensively applied in human biomedical research 
but, paradoxically, less frequently in the research of fish health issues. Farmed Atlantic 
salmon can suffer from several viral conditions affecting the heart. Therefore, species-
specific, cardiac in vitro models may represent a useful tool to help further 
understanding and management of these diseases. The mechanisms underlying 
genotype based resistance are complex and usually rely on a combined effect of 
elements from both the innate and adaptive immune response, which are further 
complicated by external environmental factors. Here we propose that Salmon Cardiac 
Primary Cultures (SCPCs) are a useful tool to investigate these mechanisms as the 
basis for genotypic differences between Atlantic salmon families in susceptibility to 
cardiotropic viral disease. 
 
Using SCPCs produced from two different commercially available Atlantic salmon  
embryonated ova (Atlantic Ova IPN sensitive” (S) and “Atlantic QTL-innOva® IPN/PD” 
(R)), the influence of host genotype on the viral load and mx expression following 
Salmon Pancreas Disease Virus infection was assessed over a 15 day period. Both R 
and S SCPCs groups were successfully infected. A measurable difference between 
groups of viral nsP1 and host antiviral mx gene expression was observed (i.e. a later, 
but larger onset of mx expression in the R group). Mx expression peaks were followed 
by a decrease in viral nsP1 in both groups. Additionally, ultrastructural examination of 
infected SCPCs allowed the description of degenerative changes at the individual cell 
level. The SCPC model presents some advantages, over current fish cell culture 
monolayers and in vivo material, such as the presence of different cell components 
normally present in the target organ, as well as the removal of a layer of functional 
complexity (acquired immunity), making it possible to focus on tissue specific, early 
innate immune mechanisms. These preliminary results highlight the importance of 
considering genetic origin when selecting the fish source for the production of SCPCs, 
as well as their usefulness as screening tools for assessment of genotypic differences 
in disease resistance.  
 
1. Introduction 
 
In the last decade an increased number of viral conditions associated with severe 
cardiomyopathy have impacted farmed salmonids, such as those caused by Piscine 
Cardiomyopathy Virus (PCMV), Piscine Reo Virus (PRV) and Salmon Pancreas 
Disease Virus (SPDV), also commonly referred to as Salmonid Alphavirus (SAV) 1–4.For 
consistency in this work and given that the first is yet the only accepted species name 
approved by the International Committee on Taxonomy of Viruses, we will refer to it as 
SPDV (ICTV Feb. 2013).   
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The focusing of this work on SPDV arises from the severe economic and animal welfare 
impact this virus has had for over 30 years,  threatening the sustainability of Atlantic 
salmon aquaculture 5,6. Variability in the outcome of the SPDV infection is provided by 
differences in virulence between  SPDV subtypes and strains 7.  However, differences 
in host susceptibility had long been suspected and were eventually confirmed through 
an epidemiological survey in Ireland, which indicated significant differences between 
diverse fish stocks, evaluated by levels of clinical disease and mortality. These 
differences were further confirmed through experimental challenges 8. 
 
The concept of host natural resistance is the basis for development of selection-based 
approaches to disease control. As is seen with humans and other animals, the wide 
variation in outcomes of a host pathogen interaction reflects a complex interplay of 
environmental and host factors. Among the most important intrinsic determinants of 
resistant/susceptibility to infection are the host genetics, and the functional diversity of 
immune response 9,10. For example, differences in the innate antiviral response 
measured as interferon (IFN) induced mx gene expression, were found between 
different cell lines of salmon origin, correlating with their resistance and susceptibility 
11,12. 
 
In vivo and in vitro fish models have been extensively used in human biomedical 
research in a wide range of fields, and notably the zebra fish (Danio rerio) is today a 
strongly established vertebrate model for the study of human disease 13–15. In vivo 
models are widely used in disease research in production fish. Paradoxically, in 
comparison the application of in vitro fish based models to study disease in production 
fish is relatively limited, although the potential is high. Traditional in vitro work using 
continuous fish cell lines has historically provided important insights; however it does 
pose certain limitations and risks. For example, contamination and replacement of the 
original cell type has been reported in EPC (Epithelioma papulosum cyprini), where 
currently used cultures were found to be contaminated by fathead minnow (Pimephales 
promelas) cells 16. There is also the possibility that mechanisms observed in vitro are 
not translatable to the live host, for instance adaptation of a virus after repetitive 
passage resulting in tissue culture adaptation and consequent loss of virulence in host 
challenge studies 17–19. Difference in in vivo versus in vitro outcomes can also be 
related to immune cell interactions, giving rise to potential for adaptive immunity in the 
former versus predominantly innate immune responses in the latter. 
 
While in vitro models are a simplified version of the host, they are desirable tools that 
could help replace or reduce the number of live animals required in experimental work 
20,21. A major drawback is the limited number of cell lines of the target species available. 
One critical aspect required to translate output from cell line models to animal is the 
availability of cell lines corresponding to the cell type present in the target organ. Using 
SCPCs it is possible to introduce several desirable factors that contribute to its 
translatability. Two such factors are increased complexity by inclusion of a mixture of 
cell types mimicking those present in the target organ, and isolation from the host 
species to which the model applies. For instance, working directly with rainbow trout 
tissues proved relevant when studying Sleeping Disease (SD), a condition in freshwater 
rainbow trout (Oncorhynchus mykiss) caused by a SPDV subtype. The use of primary 
cultures of muscle satellite cells from rainbow trout provided novel evidence that these 
cells were targeted during infection 22. In the above scenario, development of in vitro 
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salmonid cardiac models for the study of the mechanisms underlying cardiotropic viral 
diseases of salmon represents an area of interest. 
 
We developed an in vitro 3D heart primary culture model, the salmon cardiac primary 
culture (SCPC), from embryonic Atlantic salmon (Salmo salar). SCPCs contain several 
of the basic components of the fish heart, i.e. myocardium, epicardium, endocardium 
and fibroblast cells, and can be kept up to 5 months in culture with low maintenance, 
can be processed for histology, electron microscopy, and molecular techniques, and 
are permissive to viral infection and replication 23. 
 
We hypothesized that the origin of salmon eggs used to generate the SCPCs can result 
in differences in the susceptibility of the SCPC model to SPDV. To assess this, we 
compared the kinetics of infection with a virulent SPDV subtype 1 isolate (SPDV) 
between SCPCs isolated from embryos of two different, commercially available Atlantic 
salmon stocks with different genetic traits. The possibility of assessing potential 
differences in host response due to genomic variability can widen the SCPCs 
application in genomic selection studies. 
 
 
2. Material and Methods 
 
2.1. Embryo origin 
 
Commercially available embryonated eggs “Atlantic Ova IPN sensitive” (S) and “Atlantic 
QTL-innOva® IPN/PD” (R) were obtained from AquaGen® Norway (through AquaGen 
Scotland Ltd, Stirling University Innovation Park, Stirling, UK). The former has a 
genotype sensitive to Infectious Pancreatic Necrosis Virus (IPNV) and is usually 
sourced for use in vaccine trials. The Atlantic QTL-innOva® IPN/PD is a genotype with 
a combined increased resistance to both IPNV and to SPDV (pancreas disease – PD), 
as described by the manufacturer. 
 
2.2. SCPC production 
 
SCPCs were produced following protocols previously described 23. In brief, eggs from 
both genotypes, described above, were incubated separately in aerated, sterile sea 
water at 5ºC with primary isolation and harvesting of the identified cardiac tissue 
performed over a 2 week period prior to hatching. Embryos were stripped from their 
shell using sterile tweezers and scissors in a laminar flow cabinet. They were then 
transferred into 0.5 ml Trypsin (2.5% Trypsin 10x Gibco by Life Technologies-NZ), and 
mechanically dissociated to facilitate chemical digestion. The lysate was transferred into 
2ml of culture medium (L15 (Lonza, UK) supplemented with 10% foetal bovine serum 
(Sigma-Aldrich, USA), 100 U/ml Penicillin and 0.1 mg/ml Streptomycin (Fisher 
Scientific, UK)), and then centrifuged for 5 minutes at 565g at 15°C. The medium was 
then removed and 2ml of fresh medium was added pipetting vigorously to re-suspend 
the tissue pellet. Each whole embryo lysate was then plated individually into 12 well 
tissue culture plates (Cellstar-Greiner Bio-one-UK) and incubated at 20°C. Culture 
medium was then renewed at 24h simultaneously removing the non-attached cell 
debris. Plates were examined daily under a dissecting microscope (Motic-SMZ 168) to 
collect developing SCPCs. These were recognised by their morphology and their 
beating capacity, and where carefully pipetted out using 100 or 200µl tips. SCPCs were 
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then individually transferred to x8 well chambered glass slides (Nunc® Lab-Tek II, 
Thermo-Fisher-USA) with 0.5ml fresh culture media where they re-attached 
spontaneously and were incubated at 20°C. SCPCs for both genotype groups were 
isolated and cultured in parallel to ensure synchronous development during the 
experiments. 
 
2.3. Experimental design 
 
SCPCs between 2-3 weeks old were identified as “S” (sensitive) or “R” (resistant) as 
per genotype of origin, and were challenged with SPDV virus. SPDV-1 isolate F07-220 
originating from a field outbreak in Ireland, was used for the challenge. The virus was at 
passage 4 and was cultured in Chinook salmon  (Oncorhynchus tshawytscha) cells 
(CHSE-214, ATCC CRL 1681) for 7 days. Its virulence and pathogenicity had been 
tested through an in vivo challenge study (unpublished data), where it produced 
moderate to severe PD histopathological changes. SCPCs were infected synchronously 
with identical viral dose by adding 50µl of a SPDV-1 F07-220 virus stock solution 
directly into each SCPCs well to achieve a final dilution of 2.4x104 plaque forming units 
(PFU)/ml. After 2h absorption at 15ºC, the culture media was exchanged by fresh media 
both in the infected treatment and control wells and incubation continued at 15ºC.  
The experiment was run for 2 weeks using a total of 48 individual SCPCs distributed to 
have x4 infected and x2 controls per time point and genotype. Samples were taken 
individually at days 1, 10 and 15 days post infection (dpi), where 0dpi was considered 
the point of medium exchange after a 2h viral absorption for infected and uninfected 
medium exchange for controls, respectively. 
 
2.4. Quantitative PCR 
 
Extraction of mRNA was performed from individual SCPCs using Dynabeads® mRNA 
Direct™ Micro Purification Kit (Catalog Nº 61021, Ambion-ThermoFisher Scientific, UK) 
as per manufacturer’s instructions. The kit is designed to isolate highly purified mRNA 
directly from crude lysates and is especially suitable for micro-samples. Elution was 
performed in a final volume of 10μl of elution buffer (10nM Tris-HCl ph 7.5) from which 
an aliquot of 7.7μl mRNA was used for reverse transcription (RT) using a Taqman 
Reverse Transcription Reagent Kit (Applied Biosystems-ThermoFisher Scientific, UK) 
as follows: 7.7µl of mRNA and 1µl of 50µM Oligo d(T)16 (Invitrogen®, ThermoFisher 
Scientific, UK) were mixed and heated to 70 °C for 10 min and then chilled on ice. The 
final volume was adjusted to 20 µl by adding 11.3µl of Master mix, comprised of 10x RT 
buffer (25 mM Tris–HCl pH 8.3, 37.5 mM KCl, 5.5 mM MgCl2), 0.5 mM dNTP, 0.4 U 
RNase inhibitor and 1.25 U Multiscribe Reverse Transcriptase. The reaction was 
incubated at 48°C for 90 min, heat inactivated at 95°C for 5 min, and stored at -80°C 
until use. Quantitative PCR (QPCR) assays were performed on a Roche LC480 System 
(Roche). TaqMan probes and primers to amplify the elongation factor elf, mx and SPDV 
non-structural protein P1 (nsP1) are given in Gahlawat et al., 2009. Experimental 
negative controls were routinely included at the stages of extraction, reverse 
transcription and QPCR. 
 
The Ct (cycle threshold) was determined by the maximum secondary derivative method 
where the values were converted into expression levels using a standard curve 24. The 
relative expression level of target genes (mx and nsP1) were then normalized to the 
level of expression of elongation factor 1 alpha (elf), allowing for comparison within and 
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between genotypes. The errors of normalised gene expression are unlikely to be 
normally distributed and the most appropriate statistical analysis would utilise a 
permutation test. However, the combined effect of small group sizes and the need to 
correct for multiple comparisons mean that such analyses are unlikely to generate 
statistically significant p-values even if substantial biological differences are present. 
We have represented differences expressed in terms of “fold of increase”, providing 
also both points estimates (means) and estimates of variance (standard deviation). Fold 
changes were calculated by comparison to the corresponding non infected controls 
(mx) or relative to day 1 post infection (nsP1). 
 
2.5. Ultrastructural studies 
 
For ultrastructural analysis of viral tropism, an identical infection protocol was applied 
using x2 SCPCs per time point/genotype and sampling at 2, 3 and 24hours post 
infection (hpi). Samples were fixed in situ by adding 0.5 ml cold Karnovsky’s fixative 
(2.5% glutaraldehyde and 2% paraformaldehyde in 0.1M phosphate buffer pH 7.4 
(Electron Microscopy Sciences, USA) to the well and left for 30 minutes at room 
temperature. The fixative contained  Fixed SCPCs were then transferred to a 1.5 ml 
Eppendorf tube with 0.1M Phosphate buffer saline pH 7.4 (PBS) and washed for 15 
minutes on a rotator disk placed on a rocker. The procedure was repeated twice 
followed by transfer to fresh buffer for short-term storage at 4°C. The post fixation used 
1% OsO4 in 0.1 M Cacodylate buffer for 2 h at 4°C followed by dehydration using a 
graded series of ethanol. Samples were then embedded in araldite resin (Fluka, 
Switzerland) and ultrathin sections cut on an Ultracut E (LEICA, Germany). Staining 
was performed with 0.5% uranyl acetate (Laurylab, France) and 3% lead citrate 
(Laurylab) in an Ultrastainer AC20 (LEICA, Austria). Examination of stained sections 
was performed on/with a JEOL electron microscope JEM 1011 at 60 kV or JEM-1400 
Plus at 120kV (JEOL, Japan). 
 
 
3. Results and Discussion 
 
SCPCs, a species-specific cardiac model developed from A. salmon embryos, has 
been proposed as an alternative approach to traditional in vitro work using cell lines 
with the aim to support studies of host pathogen interactions of cardiotropic viral agents, 
such as SPDV affecting A. salmon. The current work used SCPCs isolated from 
commercial A. salmon strains resistant to PD/IPN (R), and susceptible to IPN (S), as 
representatives of different genetic traits. While IPNV resistance has been found to 
represent a rare case where a single major gene or quantitative trait loci (QTL) explains 
the bulk of variation in resistance due to the genotype 25,the biological basis of genetic 
resistance to SPDV is more complex (i.e. polygenic)26. This work constitutes the first 
assessment of the usefulness of the SCPC model to evaluate the potential influence of 
the host genotype in the outcome of SPDV infections. SCPCs were infected 
synchronously with identical viral dose and the QPCR Ct values were normalised 
against the individual housekeeping gene (elf), therefore it is possible to compare the 
relative expression within and between genotypes. 
 
3.1. Kinetics of mx and SPDV-nsP1  
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Both SCPCs of R or S origin showed an mx gene induction after infection with isolate 
SPDV-1 F07-220 over a 15 day period. 
 
At 1dpi the mx expression in the S group showed a 24.7 fold increase relative to its 
control, compared to only a 1.6 fold increase in the R group. This was followed by a 
substantial induction of mx in the R group by 5dpi that with a magnitude of 5700 fold 
increase represents its peak at the time the S group with a 7.7-fold increase showed a 
transient decline compared to day 1. At 10dpi the R group had a 110 fold increase 
relative to control, a decrease from its peak expression of day 5, which is then 
maintained at similar values by 15 dpi with a221 fold increase. In the S group the mx 
gene expression at 10 dpi showed a 812-fold increase representing the peak  for this 
group and it also remained at a similar magnitude by 15dpi with a 219-fold increase 
relative to controls (Fig 1a-b). 
 
The viral transcript (SPDV-nsP1) in both groups had similar expression at 1dpi but 
afterwards differences between R and S groups were observed, both in magnitude and 
in kinetics. The earliest increase in nsP1 was noted in the R group at 5dpi (2266-fold 
relative to day 1) which corresponded to the peak of mx gene expression for this group. 
This was followed by a transient decrease at 10dpi (31-fold) and a second peak of 
expression at 15dpi, with a 1619-fold increase, reaching similar levels as that of 5dpi.   
 
Conversely in the S group  nsP1 remained similar at the 2 first time points with only a 
slight increase at 5dpi, (1.4 fold) coinciding with a decreased mx expression  on that 
day. This was followed by a delayed but strong increase at 10dpi (289 fold) 
simultaneously with the increase in mx expression. Similar to observations on the the R 
group, the increased and sustained level of mx expression seemed to induce the 
subsequent marked reduction on viral gene expression observed by 15dpi (5.6 fold) 
(Fig 1a-b). 
 
 
Fig. 1 A: Kinetics of mx and SPDV-nsP1 gene expression in “R” SCPCs genotype after infection 
with isolate SPDV-1 F07-220. Values are normalised against the host reference gene elf and 
expressed in a logarithmic scale. There are 4 biological replicates/time point. DPI: days post 
infection. 
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Fig. 1B: Kinetics of mx and SPDV-nsP1 gene expression in “S” SCPCs genotype after infection 
with isolate SPDV-1 F07-220. Values are normalised against the host reference gene elf and 
expressed in a logarithmic scale. There are 4 biological replicates/time points. DPI: days post 
infection. 
 
In this study overall the mx expression of infected SCPCs after viral induction remained 
higher than control SCPCs in both groups and at all-time points. 
The baseline of mx expression on the control groups fluctuated slightly over time. The 
mx average of the controls were 0.00049 (R) and 0.00021(S). Differences in the basal 
gene expression in the unchallenged SCPCs may have been due to individual variation 
and given the small sample size in this case, further work is required to verify whether 
they are determined or not by the origin/genotype of the SCPCs. 
 
Among infected cultures, after induction both groups maintained an mx expression level 
above the base line for the length of the experiment. The S group showed an early mx 
induction followed by a transient decrease before a peak expression for the group at 
day 10pi, a delayed response compared to the peak on the R group at 5dpi. The 
magnitude of mx expression of the R group was consistently higher from day 5 onwards 
than in group S, with a general average of 0.2208 and 0.0332, respectively.  
Conversely, on average, the total viral RNA expression level was higher in the R group 
(0.0731) than the S group (0.117), suggesting a relation to the expression of mx on 
each group.   
 
Slow or reduced mx gene induction has been observed and associated with a strong 
viral replication in fish cell lines infected with IPNV 27 and SPDV19. Additionally, the 
amplitude of mx gene induction after infection with SPDV was negatively correlated with 
the viral gene expression in two salmonid cell lines that may have had different levels of 
resistance to this virus 11,12.  
There were fluctuations in the expression of viral genome level in both groups. As 
experimental settings involved terminal sampling of all replicates at each time point, the 
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terminal sampling may represent a re-infection cycle of those samples after the 2 weeks 
period. 
 
Factors other than the genetic trait itself may have influenced this outcome, including 
for example the models cell’s composition, with a higher level of complexity than 
standard cell lines. Temperature and the cell line have been reported to influence the 
culture characteristics of SPDV in vitro 28, but these factors were constant in the present 
study. The genotype R has been commercially selected for SPDV resistance (Aquagen, 
Norway) and this may explain the relatively overall stronger mx response noted in our 
study when compared with genotype S, which has not been selected for SPDV 
resistance. These results parallel previous observations.  
 
The kinetics of mx expression observed in the R group suggests a possible re-infection 
event. However if a second viral peak as occurred in the R group, would eventually also 
happened in the S group over time (after the delay on the peak response) cannot be 
ruled out with the experimental setting currently used. 
 
 
3.2. Ultrastructure  
 
Ultrastructural examination confirmed both SCPCs of R and S origin are permissive to 
infection and viral replication. Qualitative, quantitative or temporal differences in the 
viral cycle or tropism were not noted between groups with this experimental design (i.e. 
x2 SCPCs samples per group at each of 2, 3 and 24hpi). 
 
All SCPCs were alive and beating at the time of fixation. However, degenerative 
changes were observed at the individual cell level (Fig 2 A). Changes included 
mitochondrial swelling and cristolysis (Fig 2 B), cytosol dilution, hydropic degeneration, 
development of myelin figures and nuclear pyknosis (Fig 2 C-D). Intracytoplasmic viral 
like particles (Fig 2 D) were observed in cardiomyocytes, endothelial cells, fibroblast 
and occasional intraluminal leukocytes. Abundant cytoplasmic vacuolar structures such 
as cytopathic vacuoles, phagosomes and autophagosomes were observed in both 
cardiomyocyte and endothelial cells (Fig 2 D and F). Sarcomere structural loss was also 
noted. Endothelial cells seemingly developed degenerative changes earlier (3hpi) than 
cardiomyocytes (24hpi onwards) and occasionally endothelial cells were seen 
detaching (Fig 2 F). 
 
Whereas the ultrastructural study did not reveal differences between the R and S 
groups, it confirmed the permissiveness to infection of both genotypes. It also revealed 
pathological changes similar to those previously reported during in vivo studies. SPDV 
is known to establish persistent but frequently non-lethal infections, with early 
histopathological changes described as focalised individual myocardial necrosis 5,29 . 
Additionally, this work showed the involvement of endothelial cells and a potential role 
for them in SPDV virus entry. Endothelial cells from liver and brain have been reported 
as one of the pivotal target cells for viral replication in other alphaviral infections, such 
as Chikungunya virus (CHIKV) 30 and  previous in vivo infections in salmon and trout 
with SPDV have shown infection of cells resembling hypertrophied scavenger 
endothelium-like cells in the kidney 31, and their potential role in the disease was 
speculated upon suggesting the current observation of early involvement of cardiac 
endhotelium in the SPDV infection would deserve further attention. 
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Fig 2: Transmission electron micrograph of SPDV infected Salmon cardiac primary cultures at 3-24hpi. 
(A). Multifocal, single cell degeneration. A necrotic endothelial cell (black arrow heads) and a single cell 
with nuclear chromatin margination (white arrow head) and cytoplasmic hydropic degeneration (*) are 
among intact cells. Bar=2µm. (B). Single cell showing chromatin condensation (pyknosis - PN), swollen 
mitochondria, cristolysis (black arrowheads) and cytoplasmic hydropic degeneration (stars). Bar=500nm. 
(C). Early formation of intracytoplasmic myelin figures (autophagosome - arrowhead) in cell with marked 
cytosol dilution and hydropic degeneration (black stars). Adjacent normal cardiomyocyte shows abundant 
mitochondria (white stars) and intact intercalated disks (black arrows). Bar=500nm. (D). Dgeneration, 
sarcomere loss and cytosol dilution in a cardiomyocyte with large cytoplasmic vacuole (arrows) and free 
virus like particles (arrow heads). Bar 500nm. (E). Large multi-vacuolar structures (arrowhead) containing 
autophagosomes figures and electron-dense intraluminal vesicles, consistent with autophagolysosomes. 
Multilamellar bodies with whorls of membranes forming myelin type figures (arrows). Bar=500nm. (F) 
Abundant cytoplasmic vesicular structures and degenerated mitochondria in a detaching degenerating 
endothelial cell. Bar= 500nm. N=nucleus, Pn=pyknotic nuclei, Cm cardiomyocyte, E=erythrocyte, 
En=endothelial cell.  
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4. Conclusions 
 
This work used SCPCs as representative of different commercially available A. salmon 
genotypes to assess the potential of the SCPCs as a model to investigate the influence 
of host origin on the outcome of SPDV infection. Results show that after SPDV infection 
the two groups display a measurable difference on viral nsP1 and host antiviral mx 
gene expressions. 
 
The SPCPCs model does not have influence of a systemic, acquired immune response. 
This can be seen as a missing element therefore a disadvantage, however it could also 
represent a useful feature as the removal of a layer of functional complexity enables the 
focus on the study of tissue specific, early antiviral innate immune mechanisms. 
 
Despite the scope of this prospective project was limited and the fact that the 
mechanisms of genotype based host resistance for SPDV are likely to rely on a 
combined effect of host and other factors (i.e. not exclusively dependant on mx 
activation ), these results indicate that the SCPC model can be used  for screening host 
response differences to viral infection. Moreover, the model showed to be suitable for 
ultrastructure examination bringing the benefit of the cell component of the heart to be 
included in the analysis. This would open the opportunity for more comprehensive 
SPDV viral cycle studies based on the tissue of one of the most affected organs during 
the disease condition. 
 
With several viral conditions affecting the heart of Atlantic salmon the development of 
species-specific in vitro models represents a step forwards in line with current bioethics 
standards. Whilst more information is required to in order to establish the SCPCs model 
as a tool for host genotypic screening, the present results showing measurable 
differences using the trait of disease resistance are promising. Results have also 
highlighted that, depending of the scopes, there will be a need to consider the 
consistency of genetic origin when selecting source of live material for the production of 
SCPCs. Further work to confirm the robustness of the model should include increasing 
the sample size, the comparison of using single individual samples versus multiple 
SCPCs (pooling), and exploring the potential of non-destructive approaches, such as 
sequential supernatant collection. The generation of assessment panels of biomarkers 
including other relevant genes, the application of tools such as RNAseq and microarray 
hybridization as well as immunocytochemistry ad live cell imaging, could further enrich 
the applicability of the model.  
 
 
Acknowledgements 
 
Funding by Marine Scotland Science (MSS), project AQ2000 is greatly acknowledged.  
We are grateful to Dr. David Graham (formerly Agri-Food and Bioscience Institute, 
Belfast- Northern Ireland) who supplied the virus isolate used in this work. Our thanks 
go to Katherine Lester (MSS) for help and support with virus culture and maintenance 
and to Professor Dr Bernadette Dutia (University of Edinburgh), for excellent support at 
the Edinburgh University campus and for constructive feedback during the revision of 
this MS.    
 
 
 
11 
 
References 
 
1.  Løvoll M, Wiik-Nielsen J, Grove S, et al. A novel totivirus and piscine reovirus 
(PRV) in Atlantic salmon (Salmo salar) with cardiomyopathy syndrome (CMS). 
Virol J. 2010;7(1):309. doi:10.1186/1743-422X-7-309. 
2.  Palacios G, Lovoll M, Tengs T, et al. Heart and Skeletal Muscle Inflammation of 
Farmed Salmon Is Associated with Infection with a Novel Reovirus. Lindenbach 
B, ed. PLoS One. 2010;5(7):e11487. doi:10.1371/journal.pone.0011487. 
3.  McLoughlin MF, Graham DA. Alphavirus infections in salmonids – a review. J 
Fish Dis. 2007;30(9):511-531. doi:10.1111/j.1365-2761.2007.00848.x. 
4.  Boucher P, Raynard RS, Houghton G, Laurencin FB. Comparative experimental 
transmission of pancreas disease in Atlantic salmon, rainbow trout and brown 
trout. Dis Aquat Organ. 1995;22(1):19-24. doi:10.3354/dao022019. 
5.  Bruno DW, Noguera PA, Poppe TT. A Colour Atlas of Salmonid Diseases. 
Dordrecht: Springer Netherlands; 2013. doi:10.1007/978-94-007-2010-7. 
6.  McLoughlin MF, Nelson RN, McCormick JI, Rowley HM, Bryson DB. Clinical and 
histopathological features of naturally occurring pancreas disease in farmed 
Atlantic salmon, Salmo salar L. J Fish Dis. 2002;25(1):33-43. doi:10.1046/j.1365-
2761.2002.00334.x. 
7.  Graham D a, Frost P, McLaughlin K, et al. A comparative study of marine 
salmonid alphavirus subtypes 1-6 using an experimental cohabitation challenge 
model. J Fish Dis. 2011;34(4):273-286. doi:10.1111/j.1365-2761.2010.01234.x. 
8.  McLoughlin MF, Graham D a., Norris  a., et al. Virological, serological and 
histopathological evaluation of fish strain susceptibility to experimental infection 
with salmonid alphavirus. Dis Aquat Organ. 2006;72(2):125-133. 
doi:10.3354/dao072125. 
9.  Price DJ. Genetics of susceptibility and resistance to disease in fishes. J Fish 
Biol. 1985. doi:10.1111/j.1095-8649.1985.tb04291.x. 
10.  Segal S, Hill AV. Genetic susceptibility to infectious disease. Trends Microbiol. 
2003;11(9):445-448. doi:10.1016/S0966-842X(03)00207-5. 
11.  Gahlawat SK, Ellis AE, Collet B. Expression of interferon and interferon - Induced 
genes in Atlantic salmon Salmo salar cell lines SHK-1 and TO following infection 
with Salmon AlphaVirus SAV. Fish Shellfish Immunol. 2009;26(4):672-675. 
doi:10.1016/j.fsi.2009.02.021. 
12.  Collet B, Collins C. Comparative gene expression profile in two Atlantic salmon 
cell lines TO and SHK-1. Vet Immunol Immunopathol. 2009;130(1-2):92-95. 
doi:10.1016/j.vetimm.2008.12.022. 
13.  Lohr JL, Yost HJ. Vertebrate model systems in the study of early heart 
development: Xenopus and zebrafish. Am J Med Genet. 2000;97(4):248-257. 
http://www.ncbi.nlm.nih.gov/pubmed/11376436. Accessed May 12, 2016. 
14.  Nemtsas P, Wettwer E, Christ T, Weidinger G, Ravens U. Adult zebrafish heart 
as a model for human heart? An electrophysiological study. J Mol Cell Cardiol. 
2010;48(1):161-171. doi:10.1016/j.yjmcc.2009.08.034. 
15.  Pieperhoff S, Wilson KS, Baily J, et al. Heart on a plate: histological and 
functional assessment of isolated adult zebrafish hearts maintained in culture. 
PLoS One. 2014;9(5):e96771. doi:10.1371/journal.pone.0096771. 
16.  Winton J, Batts W, DeKinkelin P, LeBerre M, Bremont M, Fijan N. Current 
lineages of the epithelioma papulosum cyprini (EPC) cell line are contaminated 
with fathead minnow, Pimephales promelas, cells. J Fish Dis. 2010;33(8):701-
704. doi:10.1111/j.1365-2761.2010.01165.x. 
 
12 
 
17.  Weston JH, Graham D a, Branson E, et al. Nucleotide sequence variation in 
salmonid alphaviruses from outbreaks of salmon pancreas disease and sleeping 
disease. Dis Aquat Organ. 2005;66(2):105-111. doi:10.3354/dao066105. 
18.  Fringuelli E, Rowley HM, Wilson JC, Hunter R, Rodger H, Graham D a. 
Phylogenetic analyses and molecular epidemiology of European salmonid 
alphaviruses (SAV) based on partial E2 and nsP3 gene nucleotide sequences. J 
Fish Dis. 2008;31(11):811-823. doi:10.1111/j.1365-2761.2008.00944.x. 
19.  Matejusova I, Lester K, Li Z, Bravo J, Bland F, Collet B. Comparison of complete 
polyprotein sequences of two isolates of salmon alphavirus (SAV) type I and their 
behaviour in a salmonid cell line. Arch Virol. 2013;158(10):2143-2146. 
doi:10.1007/s00705-013-1689-4. 
20.  Collet B, Urquhart K, Monte M, et al. Individual monitoring of immune response in 
Atlantic Salmon Salmo Salar following experimental infection with infectious 
salmon anaemia virus (ISAV). PLoS One. 2015;10(9). 
21.  Drennan JD, Lapatra SE, Samson CA, Ireland S, Eversman KF, Cain KD. 
Evaluation of lethal and non-lethal sampling methods for the detection of white 
sturgeon iridovirus infection in white sturgeon, Acipenser transmontanus 
(Richardson). J Fish Dis. 2007;30(6):367-379. doi:10.1111/j.1365-
2761.2007.00817.x. 
22.  Biacchesi S, Jouvion G, Mérour E, et al. Rainbow trout (Oncorhynchus mykiss) 
muscle satellite cells are targets of salmonid alphavirus infection. Vet Res. 
2016;47(1):9. doi:10.1186/s13567-015-0301-1. 
23.  Noguera PA, Grunow B, Klinger M, et al. Atlantic salmon cardiac primary cultures: 
An in vitro model to study viral host pathogen interactions and pathogenesis. 
Vaughan L, ed. PLoS One. 2017;12(7):e0181058. 
doi:10.1371/journal.pone.0181058. 
24.  Olsvik PA, Lie KK, Jordal A-EO, Nilsen TO, Hordvik I. Evaluation of potential 
reference genes in real-time RT-PCR studies of Atlantic salmon. BMC Mol Biol. 
2005;6:21. doi:10.1186/1471-2199-6-21. 
25.  Moen T, Baranski M, Sonesson AK, Kjøglum S. Confirmation and fine-mapping of 
a major QTL for resistance to infectious pancreatic necrosis in Atlantic salmon 
(Salmo salar): population-level associations between markers and trait. BMC 
Genomics. 2009;10(1):368. doi:10.1186/1471-2164-10-368. 
26.  Gonen S, Baranski M, Thorland I, et al. Mapping and validation of a major QTL 
affecting resistance to pancreas disease (salmonid alphavirus) in Atlantic salmon 
(Salmo salar). Heredity (Edinb). 2015;115(October 2014):405-414. 
doi:10.1038/hdy.2015.37. 
27.  Larsen R, Rokenes TP, Robertsen B, Røkenes TP, Robertsen B. Inhibition of 
infectious pancreatic necrosis virus replication by atlantic salmon Mx1 protein. J 
Virol. 2004. doi:10.1128/JVI.78.15.7938-7944.2004. 
28.  Graham DA, Wilson C, Jewhurst H, Rowley H. Cultural characteristics of 
salmonid alphaviruses - Influence of cell line and temperature. J Fish Dis. 
2008;31(11):859-868. doi:10.1111/j.1365-2761.2008.00946.x. 
29.  McLoughlin MF, Nelson RT, Rowley HM, Cox DI, Grant AN. Experimental 
pancreas disease in Atlantic salmon Salmo salar post-smolts induced by salmon 
pancreas disease virus (SPDV). Dis Aquat Org. 1996;26(2):117-124. 
doi:10.3354/dao026117. 
30.  van Duijl-Richter MKS, Hoornweg TE, Rodenhuis-Zybert IA, Smit JM. Early 
Events in Chikungunya Virus Infection-From Virus Cell Binding to Membrane 
Fusion. Viruses. 2015;7(7):3647-3674. doi:10.3390/v7072792. 
 
13 
 
31.  Taksdal T, Olsen AB, Bjerkås I, et al. Pancreas disease in farmed Atlantic 
salmon, Salmo salar L., and rainbow trout, Oncorhynchus mykiss (Walbaum), in 
Norway. J Fish Dis. 2007;30(9):545-558. doi:10.1111/j.1365-2761.2007.00845.x. 
 
